US2019134252A1PendingUtilityA1
Dressings comprising platelet lysate
Est. expiryJun 29, 2036(~10 yrs left)· nominal 20-yr term from priority
Inventors:Vivek RautMeghan Elizabeth SambergKolby Luke DayBrian Roy BarnesChristopher Ronald RathbonePatrick PattersonDonald J. BrownJustin Jeffrey Baker
A61L 2300/404A61L 2300/418A61L 15/44A61L 15/40A61L 2400/04A61F 13/00063
40
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A dressing comprises a delivery vehicle and platelet lysate. The dressing can also include an antimicrobial agent, a hemostatic agent, and a binder. It is contemplated that the dressing can be used for expediting hemostasis, improving antimicrobial activity, minimizing fluid loss, and accelerating wound healing when applied to a wound. The dressing would be useful in applications including military in-theater medical care and for conditions such as diabetic foot ulcers, as well as other applications.
Claims
exact text as granted — not AI-modified1 . A dressing, comprising:
a delivery vehicle; and platelet lysate.
2 . The dressing of claim 1 , wherein the delivery vehicle is woven or non-woven gauze, allograft tissue, autograft tissue, or xenograft tissue.
3 . The dressing of claim 1 , wherein the dressing further comprises an antimicrobial agent.
4 . The dressing of claim 3 , wherein the antimicrobial agent contains silver; or
wherein the antimicrobial agent is silver sulfadiazine, silver nitrate, or silver chloride; or wherein the antimicrobial agent is iodine, chlorhexidine, bacitracin, ciprofloxacin, gentamycin, or honey.
5 . The dressing of claim 1 , wherein the dressing further comprises a hemostatic agent, wherein the hemostatic agent is kaolin, chitosan, a zeolite, or a styptic such as anhydrous aluminum sulfate, potassium permanganate, zinc oxide, or zinc sulfate.
6 . The dressing of claim 1 , wherein the dressing further comprises a binder, wherein the binder is glycerol, casein, arabic gum, xanthan gum, corn starch, wheat starch, cellulose, gelatin, pectin, chitosan, dextran, or albumin.
7 . The dressing of claim 1 , wherein the dressing further comprises an antimicrobial agent and a hemostatic agent; and wherein the delivery vehicle is a substrate.
8 . The dressing of claim 7 , wherein the platelet lysate, the antimicrobial agent, and the hemostatic agent are dispersed in a single layer upon the substrate; or
wherein the platelet lysate, the antimicrobial agent, and the hemostatic agent each form a separate layer upon the substrate.
9 . The dressing of claim 1 , wherein the delivery vehicle is a hydrogel.
10 . The dressing of claim 9 , wherein the hydrogel contains a hydrogel matrix comprising carboxymethylcellulose, collagen, fibrin, alginate, poly(lactic-co-glycolic acid), or polyethylene glycol.
11 . The dressing of claim 10 , wherein the hydrogel matrix is swelled in phosphate buffered saline; or
wherein the weight ratio of the platelet lysate to the hydrogel matrix is from about 0.25% to about 90%.
12 . The dressing of claim 1 , wherein the delivery vehicle is a powder, and wherein the powder is carboxymethylcellulose, collagen, fibrin, alginate, poly(lactic-co-glycolic acid), or polyethylene glycol.
13 . The dressing of claim 1 , wherein the delivery vehicle is a liquid carrier or a pressurized gas.
14 . The dressing of claim 13 , wherein the dressing contains a surfactant and is in the form of a shampoo; or
wherein the dressing contains a wax and is in the form of a cream; or wherein the dressing contains a gelling agent and is in the form of a gel.
15 . The dressing of claim 1 , wherein the dressing further comprises an antifungal agent.
16 . A method of making a bandage, comprising:
combining a substrate with a solution that comprises platelet lysate to obtain an impregnated substrate; freezing the impregnated substrate; and lyophilizing the impregnated substrate to obtain the bandage.
17 . The method of claim 16 , further comprising sterilizing the bandage using radiation.
18 . The method of claim 16 , wherein the substrate is impregnated with a hemostatic agent prior to being combined with the solution.
19 . The method of claim 16 , wherein the impregnated substrate is frozen at a temperature below −70° C.
20 . A method of making a dressing, comprising:
mixing a hydrogel matrix with dry platelet lysate; and gelling the hydrogel matrix with a liquid to obtain the dressing.
21 . The method of claim 20 , wherein the hydrogel matrix comprises carboxymethylcellulose, collagen, fibrin, alginate, poly(lactic-co-glycolic acid), or polyethylene glycol; or
wherein the weight ratio of the platelet lysate to the hydrogel matrix is from about 0.25% to about 90%; or wherein the liquid is phosphate buffered saline; or wherein the liquid has a pH of about 4 to about 9; or wherein the gelling occurs at a temperature of about 25° C. to about 37° C.
22 . A method for treating a condition, comprising:
applying a dressing to a body exhibiting the condition, wherein the dressing comprises a delivery vehicle and platelet lysate.
23 . The method of claim 22 , wherein the dressing is in the form of a bandage, an eye drop, a spray, a shampoo, a foam, an aerosol, a gel, a cream, or a powder mixture.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.